Keytruda

News

Its Herceptin biosimilar nearing launch, Celltrion begins wo...

South Korea’s Celltrion has started work on a biosimilar version of pembrolizumab, Merck & Co’s blockbuster immunotherapy Keytruda.

News

Keytruda not enough to lift Merck - so will it turn to M&A?

Merck & Co.

News

Keytruda approved for bladder cancer in Europe, first to pro...

Merck Sharp & Dohme’s Keytruda has been approved in Europe for metastatic urothelial carcinoma, a move which helps it catch up with its immunotherapy rivals.

News

FDA probes blood cancer immunotherapy safety

Regulator reviewing combination therapy safety after issue with Keytruda

News

Scotland decision helps Opdivo in UK market access picture

The last 18 months has seen groundbreaking cancer immunotherapies, led by BMS’s Opdivo and Merck Sharp & Dohme’s Keytruda hit the UK market, with both rapidly adding multiple indication

News

Merck soars on Keytruda combination filing

Approval by May could put Keytruda in pole position

Its Herceptin biosimilar nearing launch, Celltrion begins wo...

Keytruda not enough to lift Merck - so will it turn to M&A?

Keytruda approved for bladder cancer in Europe, first to pro...

FDA probes blood cancer immunotherapy safety

Scotland decision helps Opdivo in UK market access picture

Merck soars on Keytruda combination filing

Ambrosia's sweet $100m round, and other biofinancings

Using AI-driven synthetic personas to take your insights fur...

Keytruda

Editor's Picks